China Structural Ventricular Arrhythmias Registry - Trial NCT03821051
Access comprehensive clinical trial information for NCT03821051 through Pure Global AI's free database. This phase not specified trial is sponsored by China National Center for Cardiovascular Diseases and is currently Recruiting. The study focuses on Ventricular Arrythmia. Target enrollment is 2000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
China National Center for Cardiovascular Diseases
Timeline & Enrollment
N/A
Oct 24, 2017
Oct 24, 2027
Primary Outcome
sustained tachycardia/ ventricular fibrillation or sudden cardiac death
Summary
This is an observational, prospective, multi-center registry ,aiming at building a risk
 stratification for malignant structural ventricular arrhythmias. 2000 participants will be
 recruited from 10 centers in China,with clinical data to be abstracted from medical records
 ,and blood samples to be collected for finding promising risk indicators.The follow-up should
 be made every 6 mouths.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03821051
Non-Device Trial